Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors.
Msaouel P, Oromendia C, Siefker-Radtke AO, Tannir NM, Subudhi SK, Gao J, Wang Y, Siddiqui BA, Shah AY, Aparicio AM, Campbell MT, Zurita AJ, Shaw LK, Lopez LP, McCord H, Chakraborty SN, Perales J, Lu C, Van Alstine ML, Elashoff M, Logothetis C.
Msaouel P, et al. Among authors: chakraborty sn.
JAMA Netw Open. 2021 Aug 2;4(8):e2122998. doi: 10.1001/jamanetworkopen.2021.22998.
JAMA Netw Open. 2021.
PMID: 34459906
Free PMC article.